Product Information
RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1542 per EA under NDC 62332006360. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
1.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332006360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091689On Market Since
6/12/2022
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1542 per EA |
|---|---|
| All-time high | $0.2753 (Nov 16, 2022) |
| All-time low | $0.1380 (Nov 22, 2023) |
| 52-week high | $0.1894 |
| 52-week low | $0.1458 |
| Median price | $0.1825 |
| Average price | $0.1856 |
| Largest weekly change | +49.6% (Oct 19, 2022) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1542 per EA (NDC 62332006360), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 40.3%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?
Since Aug 10, 2022, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1380 (Nov 22, 2023) to a high of $0.2753 (Nov 16, 2022), with a median of $0.1825 per EA.
Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 1.5 MG CAPSULE, is $0.1508 per EA — about 2% below RIVASTIGMINE 1.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?
RIVASTIGMINE 1.5 MG CAPSULE (NDC 62332006360) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification